Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

The CHMP issued a positive opinion on the once-monthly RNA-targeting treatment at its October meeting, putting it on course to become the first drug for ATTR polyneuropathy in the EU that can be ...

A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that ...

Neuropathy, or nerve dysfunction ... If you’re already taking medications, it’s a good idea to talk with your healthcare professional, doctor, or pharmacist before you begin taking CBD ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), ...

[16] The reported incidence in the earlier literature varies from no neuropathy to over 90%. [1],4-8,20] This might be due to differences in patient selection or variation in the criteria used for ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

Directorate of Public Health promotes annual check-ups for diabetes patients through Makkalai Thedi Maruthuvam (MTM) to prevent complications.